Pharmacology & Therapeutics
Издатель: Elsevier · ISSN 0163-7258 · 29 статей
- Targeting long non-coding RNAs to improve therapeutic response in nervous system tumours
- Impact of intermittent hypoxia on drug-metabolizing enzymes and transporters and drug pharmacokinetics: an underestimated concern in obstructive sleep apnea patients?
- Phytocannabinoids in neurologic, neuropsychiatric, inflammatory, pain, cardiometabolic, hepatic, renal, and neoplastic disorders: Pharmacology, clinical evidence, and translational perspectives
- Emerging HER2-targeted treatment approaches for gastroesophageal cancer in the era of chemo-immunotherapy
- Emerging strategies targeting the Hippo–YAP/TEAD pathway and the translational relevance in solid tumors
- Genetically encoded chemically controlled proximity switches: Molecular design, pharmacology, and therapeutic considerations
- Editorial Board
- Targeting metabolic reprogramming in cancer: Past, present, and future
- Embarking on a new era in high-risk biochemical recurrent prostate cancer: redefining early systemic intervention
- Prospects for treatment of cerebral ischemic stroke with Hydroxysafflower Yellow A
- Targeting glycine transporter type 1 (GlyT1) in epilepsy: Pathophysiological rationale and therapeutic perspectives
- Clusterin as a therapeutic agent: Bridging the gap in brain and eye research
- Antimicrobial photodynamic therapy across ESKAPE pathogens: Efficacy, limitations, and a pathogen-adapted framework toward clinical translation
- Neuroregulation as a modulatory force in immune checkpoint inhibitor resistance: mechanistic neuro-immune crosstalk informing biomarker-led diagnosis and targetable therapeutic sensitization
- Cell death-induced chronic inflammation as a therapeutic target for metabolic dysfunction-associated steatohepatitis
- Galectin-3 and its inhibitors: Overview and perspectives
- B-cell precursor acute lymphoblastic leukaemia: origins, classification, and therapeutic advances
- Apolipoprotein E in spinal cord injury: mechanisms of lipid dysregulation, neuroinflammation, and opportunities for repair
- Drug resistance in cancer: Emerging mechanisms, translational barriers, and pharmacological strategies
- Targeting depression: Pharmacological mechanisms and therapeutic targets
- The rhythm of pressure: Circadian disruption and chronotherapy
- The regulatory and therapeutic potential of transposable elements in cancer and inflammatory diseases
- Targeting KCC2 and NKCC1 for spinal motor dysfunction: pharmacology, therapeutic opportunities, and translational roadmap
- Mitochondrial dysfunction in Alzheimer’s disease: mechanisms, pathogenic interplay, and therapeutic opportunities
- Sinoatrial node dysfunction: molecular mechanisms, arrhythmogenesis, and translational pathways toward precision therapy
- Nucleic acid therapeutics for reinvigorating p53 function in glioblastoma: concepts, limitations and recent advances
- Navigating the landscape of stem cell therapeutics: Overcoming translational hurdles via emerging technologies and regulatory frontiers
- Pharmacological targeting of ANO1/TMEM16A in cancer: from channel inhibition to protein downregulation
- Prospects for adiponectin-based therapeutics in myocardial ischemia reperfusion injury